title: Repetitive transcranial magnetic stimulation safely administered after seizure.
abstract: High-frequency repetitive transcranial magnetic stimulation (rTMS) over left dorsolateral prefrontal cortex has been clearly reported to be effective in the treatment of depression. We report a patient with treatment-resistant depression, without any known risk factors, who developed seizure during the fourth rTMS session. After written informed consent, he received further rTMS sessions under cover of antiepileptic drug valproate and improved without recurrence of seizure.
authors.forename: Dhruv
authors.initials: D
authors.lastname: Bagati
authors.forename: Sunil
authors.initials: S
authors.lastname: Mittal
authors.forename: Samir Kumar
authors.initials: SK
authors.lastname: Praharaj
authors.forename: Manish
authors.initials: M
authors.lastname: Sarcar
authors.forename: Minal
authors.initials: M
authors.lastname: Kakra
authors.forename: Pankaj
authors.initials: P
authors.lastname: Kumar
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000150:complications / Q000628:therapy; D006801:Humans; D008297:Male; D017397:Prefrontal Cortex / Q000502:physiology; D011569:Psychiatric Status Rating Scales; D012640:Seizures / Q000188:drug therapy / Q000503:physiopathology*; D050781:Transcranial Magnetic Stimulation / Q000009:adverse effects*; D014635:Valproic Acid / Q000627:therapeutic use
chemical_list: D000927:Anticonvulsants; D014635:Valproic Acid